The clinical content of preconception care: women with psychiatric conditions.

Department of Psychiatry, Albert Einstein College of Medicine/Montefiore Medical Center, Bronx, NY 10467, USA.
American journal of obstetrics and gynecology (Impact Factor: 3.97). 01/2009; 199(6 Suppl 2):S328-32. DOI: 10.1016/j.ajog.2008.09.001
Source: PubMed

ABSTRACT For a substantial proportion of women, pregnancy can be complicated by the occurrence or reoccurrence of a psychiatric condition. Psychiatric disorders during pregnancy are associated with poor obstetric outcomes, higher risk of postpartum psychiatric illness, increased rates of substance abuse, lower participation in prenatal care, and adverse infant and family outcomes. As part of preconception care, providers should be vigilant and screen for psychiatric disorders among women of reproductive age, as the detection and appropriate management of these conditions can reduce the occurrence of adverse pregnancy and family outcomes. This manuscript reviews the treatment options and the risks and benefits of discontinuing, changing, or continuing psychotropic medications for women of reproductive age with common psychiatric disorders (depression and anxiety disorders, bipolar disorder, and schizophrenia) and offers recommendations for preconception care.

  • [Show abstract] [Hide abstract]
    ABSTRACT: This article outlines guidelines for preconception counseling of women with schizophrenia. Preconception care creates the opportunity to address risky behaviors, change unhealthy lifestyles, enhance the patient's knowledge about the genetics of her disease and the risk for her offspring, improve parenting skills, mobilize resources and the necessary support system in a timely manner and ultimately improve the health and quality of life of both the woman and her offspring. Women with schizophrenia are in particular need of preconception interventions. They are at a high risk of relapse during pregnancy unless their illness is treated. Psychosis during pregnancy can lead to fetal distress, denial of pregnancy, failure to participate in prenatal care and to recognize the signs of labor. Women with schizophrenia are at high risk of fetal malformations, obstetrical and neonatal complications and postpartum psychosis. In addition, schizophrenia is associated with homelessness and low socioeconomic status. Moreover, women with schizophrenia have poor social support and often lose the custody of their children. Identification and treatment of women with severe mental illness prior to conception is essential to reducing negative outcomes.
    Current Women s Health Reviews 01/2010; 6(1):12-16.
  • [Show abstract] [Hide abstract]
    ABSTRACT: Depression during pregnancy affects 10--20% of pregnant women and can have detrimental effects (short and long term) for the mother, fetus and family. The use of antidepressants during pregnancy has been the subject of much debate. Recent data suggest a possible risk to the fetus with maternal use of antidepressants. Selective serotonin reuptake inhibitors have been associated with congenital malformations, negative pregnancy outcomes, neonatal behavioral symptoms and persistent pulmonary hypertension of the newborn. Women with depression tend to discontinue their medication when trying to conceive or upon discovering they are pregnant, placing themselves at increased risk of recurrence of their affective illness. Therefore, it is important for clinicians to understand the risks and benefits of antidepressant use during pregnancy in order to appropriately counsel women. The purpose of this article is to review updated information regarding the use of antidepressants during pregnancy.
    Expert Review of Obstetrics &amp Gynecology 04/2011; 6(3):285-294.

Full-text (2 Sources)

Available from
May 27, 2014